KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Castle Biosciences (CSTL) Interest Expenses (2018 - 2026)

Castle Biosciences' Interest Expenses history spans 8 years, with the latest figure at $24000.0 for Q4 2025.

  • On a quarterly basis, Interest Expenses fell 73.91% to $24000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $86000.0, a 83.56% decrease, with the full-year FY2025 number at $86000.0, down 85.1% from a year prior.
  • Interest Expenses hit $24000.0 in Q4 2025 for Castle Biosciences, roughly flat from $24000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for CSTL hit a ceiling of $216000.0 in Q2 2024 and a floor of $1000.0 in Q4 2021.
  • Historically, Interest Expenses has averaged $37529.4 across 5 years, with a median of $6000.0 in 2022.
  • Biggest five-year swings in Interest Expenses: plummeted 99.75% in 2021 and later skyrocketed 9950.0% in 2024.
  • Tracing CSTL's Interest Expenses over 5 years: stood at $1000.0 in 2021, then soared by 300.0% to $4000.0 in 2022, then crashed by 50.0% to $2000.0 in 2023, then soared by 4500.0% to $92000.0 in 2024, then crashed by 73.91% to $24000.0 in 2025.
  • Business Quant data shows Interest Expenses for CSTL at $24000.0 in Q4 2025, $24000.0 in Q3 2025, and $21000.0 in Q2 2025.